Victor Daniel Rosenthal,Ruijie Yin,Camilla Rodrigues,Sheila Nainan Myatra,Jigeeshu Vasishth Divatia,Sanjay K. Biswas,Anjana Mahesh Shrivastava,Mohit Kharbanda,Bikas Nag,Yatin Mehta,Smita Sarma,Subhash Kumar Todi,Mahuya Bhattacharyya,Arpita Bhakta,Chin Seng Gan,Michelle Siu Yee Low,Marissa Bt Madzlan Kushairi,Soo Lin Chuah,Qi Yuee Wang,Rajesh Chawla,Aakanksha Chawla Jain,Sudha Kansal,Roseleen Kaur Bali,Rajalakshmi Arjun,Narangarav Davaadagva,Ider Bat-Erdene,Tsolmon Begzjav,Mat Nor Mohd Basri,Chian-Wern Tai,Pei-Chuen Lee,Swee-Fong Tang,Kavita Sandhu,Binesh Badyal,Ankush Arora,Deep Sengupta,Lili Tao,Zhilin Jin

Abstract:Background: Our objective was to identify central line (CL)-associated bloodstream infections (CLABSI) rates and risk factors (RF) in Asia. Methods: From 03/27/2004 to 02/11/2022, we conducted a multinational multicenter prospective cohort study in 281 ICUs of 95 hospitals in 44 cities in 9 Asian countries (China, India, Malaysia, Mongolia, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam). For estimation of CLABSI rate we used CL-days as denominator and number of CLABSI as numerator. To estimate CLABSI RF for we analyzed the data using multiple logistic regression, and outcomes are shown as adjusted odds ratios (aOR). Results: A total of 150,142 patients, hospitalized 853,604 days, acquired 1514 CLABSIs. Pooled CLABSI rate per 1000 CL-days was 5.08; per type of catheter were: femoral: 6.23; temporary hemodialysis: 4.08; jugular: 4.01; arterial: 3.14; PICC: 2.47; subclavian: 2.02. The highest rates were femoral, temporary for hemodialysis, and jugular, and the lowest PICC and subclavian. We analyzed following variables: Gender, age, length of stay (LOS) before CLABSI acquisition, CL-days before CLABSI acquisition, CL-device utilization ratio, CL-type, tracheostomy use, hospitalization type, ICU type, facility ownership and World Bank classifications by income level. Following were independently associated with CLABSI: LOS before CLABSI acquisition, rising risk 4% daily (aOR = 1.04; 95% CI = 1.03–1.04; p < 0.0001); number of CL-days before CLABSI acquisition, rising risk 5% per CL-day (aOR = 1.05; 95% CI 1.05–1.06; p < 0.0001); medical hospitalization (aOR = 1.21; 95% CI 1.04–1.39; p = 0.01); tracheostomy use (aOR = 2.02;95% CI 1.43–2.86; p < 0.0001); publicly-owned facility (aOR = 3.63; 95% CI 2.54–5.18; p < 0.0001); lower-middle-income country (aOR = 1.87; 95% CI 1.41–2.47; p < 0.0001). ICU with highest risk was pediatric (aOR = 2.86; 95% CI 1.71–4.82; p < 0.0001), followed by medical-surgical (aOR = 2.46; 95% CI 1.62–3.75; p < 0.0001). CL with the highest risk were internal-jugular (aOR = 3.32; 95% CI 2.84–3.88; p < 0.0001), and femoral (aOR = 3.13; 95% CI 2.48–3.95; p < 0.0001), and subclavian (aOR = 1.78; 95% CI 1.47–2.15; p < 0.0001) showed the lowest risk. Conclusions: The following CLABSI RFs are unlikely to change: country income level, facility-ownership, hospitalization type, and ICU type. Based on these findings it is suggested to focus on reducing LOS, CL-days, and tracheostomy; using subclavian or PICC instead of internal-jugular or femoral; and implementing evidence-based CLABSI prevention recommendations.

Implementation and Long-term Efficacy of a Multifaceted Intervention to Reduce Central Line-Associated Bloodstream Infections in Intensive Care Units of a Low Middle-Income Country

CLABSI reduction using evidence based interventions and nurse empowerment: a quality improvement initiative from a tertiary care NICU in Pakistan

Decreasing Central Line-Associated Bloodstream Infections Rates in Intensive Care Units in 30 Low- and Middle-Income Countries: an INICC Approach.

Evaluating the outcome of a bundle with 11 components and the INICC multidimensional approach in decreasing rates of central line-associated bloodstream infections across nine Asian countries

Successful Reduction in Central Line–associated Bloodstream Infections in a Chinese Neonatal Intensive Care Unit

Multistate programme to reduce catheter-associated infections in intensive care units with elevated infection rates

Application of Multi-Department Cooperation, Intelligent Prevention, and Supervision to Reduce the Incidence of Central Line-Associated Bloodstream Infections

Multinational prospective study of incidence and risk factors for central-line-associated bloodstream infections in 728 intensive care units of 41 Asian, African, Eastern European, Latin American, and Middle Eastern countries over 24 years

Implementation of the Comprehensive Unit-Based Safety Program to Improve Infection Prevention and Control Practices in Four Neonatal Intensive Care Units in Pune, India

Study on intervention in central line-associated bloodstream infection in intensive care units

Incidence, risk factors and associated mortality of central line-associated bloodstream infections at an intensive care unit in northern India

Initiation of interdisciplinary prevention rounds: decreasing CLABSIs in critically ill children

Dissemination of a simulation-based mastery learning intervention reduces central line-associated bloodstream infections

Multinational Prospective Cohort Study of Incidence and Risk Factors for Central Line-Associated Bloodstream Infections over 18 Years in 281 ICUs of 9 Asian Countries

Monitoring and Outcomes of Central Line-Associated Bloodstream Infections in a Tertiary Care Intensive Care Unit

Reducing ambulatory central line‐associated bloodstream infections: A family‐centered approach

Assessment of the Level of Awareness and Degree of Implementation of Central Line Bundles for Prevention of Central Line-associated Blood Stream Infection: A Questionnaire-based Observational Study

Development of best evidence-based practice protocols for central venous catheter placement and maintenance to reduce CLABSI

Effectiveness of insertion and maintenance bundles to prevent central-line-associated bloodstream infections in critically ill patients of all ages: a systematic review and meta-analysis

Targeting prolonged short-term central venous catheters to reduce hospital-wide catheter days and CLABSI rates